I have just seen an article about a new treatment for AF in the pipeline. It has many stages to go through before being launched in 2024. It sounds similar to Ablation.
The company’s treatment is called mPEF – micro-pulsed electric field.
''“In a nutshell, we have developed a technology that selectively targets the origin of the problem from outside rather than inside the heart and that’s very novel,” says AtriAN Medical co-founder and chief executive Ken Coffey. “Our technology involves using a catheter to deliver short pulses of electrical energy into the clusters of neuronal cells in which the arrhythmia originates. It destroys these cells without damaging the heart muscle and as such will provide a safe, durable and long-term solution for the treatment of AFib''
This sounds identical to the tech being developed by Iowa Approach (who just raised another $18m this year (total $32m raised to date this last 6 years):
My mother has had afib for over 25 yrs. Now she has afib and tachycardia. Boy , could she have used something like this to give her relief a long time ago.
Fantastic news I had an ablation in 2018 and ended up in an induced coma for three weeks so this external procedure sounds a much better way my heart bled out and swelled to the stage that I needed a tampanard.
Hi Cookery that sounds like a horrible experience, I hope you are doing well now.
I posted this thread back in in 2018, since then In 2019 Atrian Medical raised €2.3m in seed funding and the first patient trials of the treatment are due to take place this year details below....
I understand Dr. Asirvatham an electrophysiologist at Mayo Clinic in the USA is involved with both these new forms of treatment, he has some very interesting ideas about the causes and treatment of AF .
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.